Stereotactic radiosurgery using charged-particle beams has been the subject
of biomedical research and clinical development for more than 50 years. Ch
arged particles of proton mass or greater manifest unique physical properti
es that can be used to place a high dose of radiation preferentially within
the boundaries of a deeply located intracranial target volume. Since 1954,
nearly 10000 patients have been treated using this technique. Treated diso
rders include pituitary tumors, vascular malformations, primary and metasta
tic brain tumors, and subfoveal neovascularization. Charged-particle radios
urgery is particularly advantageous for the conformal treatment of large an
d/or irregularly shaped lesions, or for the treatment of lesions located in
front of or adjacent to sensitive brain structures.